NCT02327182View on ClinicalTrials.gov

Safety Study of MT-4666 in Subjects With Alzheimer's Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Alzheimer's Disease
Interventions
DRUG

MT-4666

Trial Locations (1)

Unknown

Investigational site, Osaka

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY